MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
322.23%
Quick Ratio
322.23%
Debt to Asset Ratio
27.70%
Unit: Thousand (K) dollars
Assets Breakdown
    • Royalty receivable, long term
    • Cash and cash equivalents
    • Right of use assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
9,189
8,419
7,483
7,115
Royalty receivable, current portion
3,394
3,211
3,525
3,665
Prepaid and other current assets
3,538
3,633
3,437
3,723
Total current assets
16,121
15,263
14,445
14,503
License rights and other intangible assets, net
3,559
3,667
3,761
3,914
Right of use assets, net
4,828
5,062
5,293
5,515
Royalty receivable, long term
12,626
13,170
13,713
14,269
Other non-current assets
395
419
444
470
Total assets
37,529
37,581
37,656
38,671
Accounts payable
460
15
377
263
Accrued expenses and other current liabilities
1,876
2,229
1,741
2,015
Current liabilities of discontinued operations
2,667
2,667
2,667
2,667
Total current liabilities
5,003
4,911
4,785
4,945
Operating lease liabilities
4,521
4,824
5,122
5,411
Other non-current liabilities
873
873
873
871
Total liabilities
10,397
10,608
10,780
11,227
Common stock, par value 0.001 640,000 and 32,000 shares authorized, 11,574 and 11,574 issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
11
11
11
11
Additional paid-in capital
979,262
979,258
979,256
979,205
Accumulated deficit
-952,141
-952,296
-952,391
-951,772
Total stockholders equity
27,132
26,973
26,876
27,444
Total liabilities and stockholders equity
37,529
37,581
37,656
38,671
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$9,189K (51.41%↑ Y/Y)Prepaid and othercurrent assets$3,538K (-3.04%↓ Y/Y)Royalty receivable,current portion$3,394K (-9.32%↓ Y/Y)Total current assets$16,121K (19.76%↑ Y/Y)Royalty receivable,long term$12,626K (-14.92%↓ Y/Y)Right of use assets,net$4,828K (-15.77%↓ Y/Y)License rights and otherintangible assets, net$3,559K (-11.97%↓ Y/Y)Other non-currentassets$395K (-7.71%↓ Y/Y)Total assets$37,529K (-2.53%↓ Y/Y)Total liabilities andstockholders equity$37,529K (-2.53%↓ Y/Y)Total stockholdersequity$27,132K (-0.59%↓ Y/Y)Total liabilities$10,397K (-7.27%↓ Y/Y)Accumulated deficit-$952,141K (-0.02%↓ Y/Y)Additional paid-in capital$979,262K (0.01%↑ Y/Y)Total currentliabilities$5,003K (7.31%↑ Y/Y)Operating leaseliabilities$4,521K (-20.93%↓ Y/Y)Other non-currentliabilities$873K (4.93%↑ Y/Y)Common stock, par value0.001 640,000 and...$11K (0.00%↑ Y/Y)Current liabilities ofdiscontinued operations$2,667K (-2.02%↓ Y/Y)Accrued expenses andother current...$1,876K (17.99%↑ Y/Y)Accounts payable$460K (31.43%↑ Y/Y)

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. (TXMD)